Jennifer K. Simpson - 13 Sep 2021 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
President and CEO, Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol
PBLA
Transactions as of
13 Sep 2021
Net transactions value
$0
Form type
4
Filing time
15 Sep 2021, 18:00:33 UTC
Previous filing
11 Aug 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Employee Stock Option (right to buy) Award $0 +19,125 $0.000000 19,125 13 Sep 2021 Common Stock 19,125 $2.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is schedule to vest in three equal annual installments on September 13, 2022, 2023 and 2024.